BPC 157 by Dragon Pharma

Dragon Pharma Original Formula

BPC-157

Pentadecapeptide•2 mg vial
Class Recovery Peptide
Half-Life ~4 hours
Action Localised Repair
Suppression None (HPG)
Reconstitution Bacteriostatic Water
Form Subcutaneous Vial
Manufactured by Dragon Pharma Third-Party Tested
Availability: In Stock
$40.00
Quantity
Shipping
  • International
  • U.S. Domestic
Wishlist

BPC-157 (Pentadecapeptide) by Dragon Pharma

BPC-157 is Dragon Pharma's formulation of the pentadecapeptide BPC-157 at 2mg per vial — a 15 amino acid peptide derived from a protective protein found in gastric juice, widely used for its localised tissue-healing properties. Supplied as a lyophilised vial requiring reconstitution, BPC-157 is dosed via subcutaneous injection, often near the site of injury.

Also searched as: BPC 157 peptide, pentadecapeptide BPC-157, BPC-157 2mg vial, BPC 157 Dragon Pharma.

What Is BPC-157?

BPC-157 (Body Protecting Compound 157) is a synthetic pentadecapeptide — a stable fragment derived from a larger protective protein naturally present in gastric juice. Its name reflects its origin: research into gastric protection led to the discovery of its broader tissue-healing properties across tendons, ligaments, muscle and the gastrointestinal tract. Unlike systemic recovery peptides, BPC-157 is most effective when administered near the specific site requiring repair, making injection location a meaningful part of how it's used.

Effects and Benefits

  • Localised healing support for tendons, ligaments and muscle tissue when injected near the injury site
  • Support for gastrointestinal tissue, reflecting its origin as a gastric-protective compound
  • Commonly used for joint-related discomfort, particularly during periods of increased training load
  • No suppression of natural testosterone — does not require Post Cycle Therapy
  • Favourable safety profile with minimal reported side effects in available research

Dosage and Administration

Use Case Typical Dose Frequency
General recovery support 250 mcg Once or twice daily
Targeted injury (near site) 250–500 mcg Once or twice daily, near injury

For localised injuries — a specific joint, tendon or muscle — subcutaneous injection near the affected area is the typical approach. For more general recovery support without a specific target area, injection site location is less critical. BPC-157's short half-life (~4 hours) means once or twice daily dosing is standard, often continued over several weeks for an injury-focused protocol.

Side Effects

BPC-157 has a favourable safety profile with minimal reported side effects:

  • Injection site reactions are possible but generally mild
  • No impact on testosterone, estrogen or the HPG axis — does not suppress natural hormone production
  • No PCT required — can be used during AAS cycles, during PCT, or independently at any time
  • As with all peptides, product sourcing and proper reconstitution matter for integrity and consistency

BPC-157 vs BPC-157 + TB-500 Blend

Dragon Pharma offers BPC-157 both standalone and as a pre-combined blend:

BPC-157 alone is well suited to a specific, localised injury where the systemic action of TB-500 isn't the priority. The blend is more practical for users wanting both localised and systemic support without managing two vials, while standalone BPC-157 offers the most direct, targeted option for a single problem area.

Reconstitution and Storage

BPC-157 is supplied as a lyophilised powder requiring reconstitution with bacteriostatic water before use. Add the bacteriostatic water slowly along the vial wall and swirl gently — do not shake. Store the reconstituted vial refrigerated at 2-8°C, stable for approximately 28-30 days. Never freeze a reconstituted peptide vial. Calculate the exact reconstitution volume based on your intended dose before adding the bacteriostatic water.

"BPC-157 is formulated as a high-purity 2mg pentadecapeptide vial, reflecting one of the most widely used recovery peptides among our customers for joint and connective tissue support."

Stacking and Related Compounds

BPC-157 is often combined with:

  • TB-500 for systemic recovery alongside BPC-157's localised action
  • Dragontropin (HGH) for users combining direct GH elevation with peptide-based recovery support
  • Cypionat 250 or other testosterone bases as part of a broader cycle this recovery peptide supports
Please log in to write review.

BPC-157 is most effective when delivering its healing effects locally — injecting near a specific tendon, ligament or muscle injury concentrates its action where it's needed, which is why injection location is emphasised more for BPC-157 than for systemic peptides.

BPC-157's origin as a gastric-protective compound is reflected in research into gastrointestinal tissue support. Some users use it specifically for digestive-related concerns, though its bodybuilding use is more commonly associated with joint and connective tissue recovery.

Protocols for specific injuries often run several weeks of once or twice daily dosing, continuing through the recovery period. There's no fixed universal duration — it depends on the nature and severity of the issue being addressed.

Standalone BPC-157 suits a specific, localised injury where systemic recovery isn't the priority, or where you want to dose BPC-157 and TB-500 separately. The blend is more practical if you want both localised and systemic support without managing two vials.

No. BPC-157 does not affect testosterone, estrogen or the HPG axis, and has no known interaction with AAS pharmacology. It's commonly used during cycles specifically to help manage the increased connective tissue stress from rapid strength gains.

BPC-157 still has systemic availability and some general recovery support occurs regardless of injection location, but its localised healing effect is generally considered most pronounced when administered close to the specific area requiring repair.

Related Products